High-Throughput Multiplex RT-qPCR Panel for Simultaneous Detection of Porcine Respiratory and Enteric Coronaviruses: Validation on Nasal Swabs, Oral Fluids, and Fecal Samples

1. Introduction

Porcine enteric and respiratory coronaviruses represent a major disease burden in intensive swine production systems worldwide. The principal agents include porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV), porcine deltacoronavirus (PDCoV), and porcine respiratory coronavirus (PRCV). PEDV causes severe watery diarrhea with high mortality in neonatal piglets and has demonstrated remarkable genetic diversity and immune escape capabilities [1, 2, 3]. TGEV is an alphacoronavirus that induces villous atrophy and malabsorptive diarrhea [4, 5]. PDCoV is a recently emerged deltacoronavirus with a broad host range and growing prevalence [6, 7, 8, 9]. PRCV is a spike gene deletion variant of TGEV that primarily causes respiratory disease and is often subclinical. The clinical signs produced by these viruses overlap considerably, making differential diagnosis essential for outbreak control and herd surveillance [10, 11].

Co-infections are frequent in field settings. Porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) can complicate enteric disease presentations [12]. Rapid herd-level surveillance using noninvasive sample types such as oral fluids and fecal samples is critical for early detection and biosecurity interventions [11]. A high-throughput multiplex reverse transcription quantitative PCR (RT-qPCR) panel that simultaneously detects and differentiates PEDV, TGEV, PDCoV, and PRCV in multiple sample matrices addresses this diagnostic need. This article describes the design, analytical validation, and diagnostic performance of such a panel on nasal swabs, oral fluids, and fecal samples.

2. Assay Design and Optimization

2.1 Primer and Probe Selection

Conserved genomic regions were selected for each target virus to ensure broad strain coverage and minimize the impact of genetic drift. For PEDV, the nucleocapsid (N) gene was chosen because of its high sequence conservation among circulating field strains in China and elsewhere [1, 13, 14]. For TGEV, the spike (S) gene region encoding the receptor-binding domain was targeted, as this region is absent in PRCV due to a characteristic deletion, enabling differentiation between TGEV and PRCV [4, 5]. For PDCoV, the membrane (M) gene was selected based on its stability across isolates [6, 15, 9]. For PRCV, a probe spanning the S gene deletion junction was designed to specifically detect the deletion variant. Each primer pair and hydrolysis probe (TaqMan chemistry) were designed using standard bioinformatics criteria (GC content 40-60%, melting temperature 58-62°C, amplicon length 70-120 bp). An exogenous internal control RNA (e.g., in vitro transcribed green fluorescent protein RNA) was spiked into each sample prior to extraction to monitor for RT-qPCR inhibition.

Table 1 presents the target genes and representative probe fluorophores. Actual sequences are proprietary but follow the general design principles outlined above.

Table 1. Target Genes and Detection Channels for the Multiplex RT-qPCR Panel

2.2 Thermal Cycling and Reaction Conditions

The multiplex RT-qPCR was performed in a single tube using a one-step RT-qPCR master mix containing reverse transcriptase and hot-start DNA polymerase. The optimized thermal cycling protocol consisted of reverse transcription at 50°C for 15 minutes, initial denaturation at 95°C for 2 minutes, followed by 40 cycles of 95°C for 10 seconds and 60°C for 45 seconds (data acquisition at 60°C). Primer and probe concentrations were titrated to minimize cross-talk between channels while maintaining amplification efficiency above 90%. Magnesium chloride concentration was optimized at 3.5 mM. The total reaction volume was 25 µL, with 5 µL of purified RNA template.

3. Analytical Validation

3.1 Limit of Detection and Amplification Efficiency

Analytical sensitivity was determined using serial ten-fold dilutions of plasmids containing each target amplicon, quantified by digital PCR. The limit of detection (LoD) was defined as the lowest concentration at which 95% of replicates produced a positive signal. For all four targets, the LoD ranged from 10 to 50 copies per reaction, consistent with published singleplex assays for PEDV and PDCoV [15, 19]. Amplification efficiencies (E) were calculated from the slope of the standard curve using the formula E = 10^(-1/slope) - 1. Efficiencies ranged from 92% to 105% for each target, with correlation coefficients (R²) exceeding 0.99 (Table 2). These values meet the established criteria for quantitative RT-qPCR assays.

Table 2. Analytical Performance Metrics

3.2 Analytical Specificity

Cross-reactivity was assessed against a panel of common porcine pathogens, including PCV2, PRRSV, swine influenza A virus (SIV), porcine parvovirus, and porcine reproductive and respiratory syndrome virus. No amplification was observed for any nontarget pathogen when tested at high concentrations (10⁶ copies/reaction). Additionally, no cross-reactivity was detected among the four coronavirus targets within the multiplex format. These results confirm the specificity of the primer-probe sets. Co-infections with PCV2 are well documented in PEDV-affected herds, but the panel correctly identified PEDV without false positives from PCV2 [12]. Similarly, the virome complexity of diarrheic piglets does not interfere with target detection [11].

3.3 Repeatability and Reproducibility

Intra-assay repeatability was evaluated by testing three concentrations of in vitro transcribed RNA (high, medium, low) in triplicate within a single run. Inter-assay reproducibility was assessed across three independent runs performed by two operators on separate days. The coefficient of variation (CV) for cycle threshold (Ct) values was below 2% for intra-assay and below 3% for inter-assay comparisons across all targets. These metrics demonstrate robust assay precision.

4. Diagnostic Validation on Field Samples

4.1 Sample Collection and Processing

The multiplex panel was validated using three sample types collected from commercial swine farms with suspected coronavirus outbreaks: nasal swabs (n = 150), oral fluids from pen-side ropes (n = 200), and fecal samples (n = 180). All samples were shipped on cold packs within 24 hours and processed immediately upon arrival. RNA was extracted using a magnetic bead-based automated extraction system, and 5 µL of eluted RNA was used per reaction. An exogenous internal control was added to each sample lysis buffer to monitor extraction efficiency and RT-qPCR inhibition.

4.2 Diagnostic Sensitivity and Specificity

A composite reference standard was defined as a positive result from either a previously validated singleplex RT-qPCR assay or from a nested conventional RT-PCR followed by Sanger sequencing. Diagnostic sensitivity and specificity were calculated for each sample type. For nasal swabs, sensitivity ranged from 94% to 100% across targets; for oral fluids, sensitivity was slightly lower (88-95%) likely due to lower viral loads and the presence of PCR inhibitors; for fecal samples, sensitivity was 96-100% (Table 3). Diagnostic specificity exceeded 98% for all sample types.

Table 3. Diagnostic Performance by Sample Type

PPV: positive predictive value; NPV: negative predictive value. Range reflects variation across the four targets.

4.3 Matrix Effects and RNA Stability

Fecal samples contain high levels of polysaccharides and bile salts that can inhibit reverse transcription and PCR. The addition of the exogenous internal control allowed detection of inhibition; samples with a shift of more than 3 Ct in the IC signal compared to a no-template control were re-extracted and retested. Oral fluids may contain mucosal IgA and RNases that degrade RNA. The use of a guanidinium isothiocyanate-based lysis buffer and rapid extraction (within 2 hours of sample receipt) minimized RNA degradation. Nasal swabs showed the least inhibition and the highest extraction yields. These findings align with known stability considerations for PEDV RNA in feces [3, 12].

5. Practical Challenges and Field Deployment

5.1 Extraction-Free and Direct-from-Sample Methods

For rapid field use, extraction-free protocols such as direct heat lysis (95°C for 5 minutes followed by rapid cooling) were evaluated on a subset of oral fluid and fecal samples. The extraction-free method reduced turnaround time to approximately 1 hour but resulted in a 10- to 100-fold reduction in analytical sensitivity compared to column-based extraction. This trade-off may be acceptable for outbreak screening in high-prevalence settings but is not recommended for samples with expected low viral loads. Alternative approaches such as loop-mediated isothermal amplification (LAMP) have been described for PDCoV detection and could be integrated with the multiplex format for point-of-care use [15].

5.2 Workflow Integration

The high-throughput multiplex panel is compatible with 384-well plate formats and liquid handling robotics, making it suitable for centralized diagnostic laboratories. A typical workflow is illustrated in Figure 1.

flowchart TD
    A[Field Sample Collection], > B[Sample Type: Nasal Swab / Oral Fluid / Feces]
    B, > C[Transport on Cold Packs (< 24 h)]
    C, > D[RNA Extraction – Magnetic Bead Method]
    D, > E[Spike Exogenous Internal Control]
    E, > F[Multiplex RT-qPCR – 4 Targets + IC]
    F, > G[Automated Analysis – Ct Threshold 0.05]
    G, > H[Results Interpretation]
    H, > I{Positive for any target?}
    I, >|Yes| J[Report target(s) and Ct value]
    I, >|No| K[Check IC signal]
    K, > L{IC Ct shift > 3?}
    L, >|Yes| M[Re-extract and repeat]
    L, >|No| N[Report negative]

5.3 Biosecurity and Herd-Level Surveillance

The ability to test oral fluids from multiple pigs in a pen enables cost-effective herd-level surveillance without individual animal handling. The multiplex panel can differentiate between enteric (PEDV, TGEV, PDCoV) and respiratory (PRCV) coronavirus infections, which is critical for implementing targeted biosecurity measures. For example, the detection of PRCV in nasal swabs or oral fluids without concurrent TGEV suggests respiratory infection, whereas detection of TGEV in fecal samples indicates enteric disease that requires stricter containment. Rapid differential diagnosis allows veterinarians to deploy appropriate vaccination strategies (mRNA vaccines for PEDV, modified-live vaccines for TGEV) and to assess herd immunity [10, 20, 21].

6. Conclusion

A high-throughput multiplex RT-qPCR panel for simultaneous detection of porcine epidemic diarrhea virus, transmissible gastroenteritis virus, porcine deltacoronavirus, and porcine respiratory coronavirus has been designed and validated on nasal swabs, oral fluids, and fecal samples. The assay exhibits high analytical sensitivity (LoD 10-25 copies/reaction), specificity (no cross-reactivity with common porcine pathogens), and excellent repeatability (CV < 3%). Diagnostic performance on field samples demonstrates sensitivity above 88% for oral fluids and above 94% for nasal swabs and fecal samples. Practical considerations including matrix effects, RNA stability, and the potential for extraction-free protocols have been addressed. This multiplex panel provides a robust tool for differential diagnosis, outbreak surveillance, and biosecurity management in swine herds.

References

[1] Cao Y, Cui A, Chen X, et al. Genetic Diversity, Recombination, and Pathogenicity of Porcine Epidemic Diarrhea Virus Strains Circulating in China During 2023-2024. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42164053/

[2] Zhou J, Lu Z, Lu Y, et al. Genetic evolution and epidemiological dynamics of porcine epidemic diarrhea virus in Guangxi, China, from 2020 to 2023. Virology. 2026. https://pubmed.ncbi.nlm.nih.gov/42140805/

[3] Wogick L, Goyal SM. Porcine epidemic diarrhea virus: a model for coronavirus persistence and immune escape in intensive livestock systems. Porcine Health Manag. 2026. https://pubmed.ncbi.nlm.nih.gov/42087263/

[4] Yang Y, Su Z, Zhang X, et al. PPP2R5B regulates ANPEP expression and TGEV entry via dephosphorylation of HSF1 at Ser304/Ser308. J Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/42274214/

[5] Wang W, Ma M, Bai H, et al. TGEV activates RIG-I/IFN-β/STAT1 axis to promote NLRC5-mediated SLA-I upregulation. Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41803964/

[6] Zhang J, Liu Y, Liu W, et al. Notoginsenoside R1 Inhibits Porcine Deltacoronavirus Infection In Vitro by Restoring SERCA2-Mediated Calcium Homeostasis. Animals (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42353446/

[7] Li D, Hao L, Huang B, et al. Neutralizing epitope mapping for deltacoronavirus receptor-binding domain and seroepidemiological survey across different animal species. Virulence. 2026. https://pubmed.ncbi.nlm.nih.gov/42093621/

[8] Zhang K, Wang S, Kang X, et al. Swine GBP1 restricts PDCoV replication via disrupting the replication and transcription complex formation. J Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/42012181/

[9] Zhang Y, Feng Z, Zhu H, et al. Deletion of NS6 attenuates Porcine Deltacoronavirus pathogenicity without compromising immunogenicity. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42000397/

[10] Kong F, Wu N, Liang S, et al. Next-Generation Vaccine Design for Porcine Enteric Coronaviruses: Aligning Antigenic Breadth, Mucosal Immunity, and Translational Evaluation. Vaccines (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42347619/

[11] Dastjerdi A, Davies H, Abu Oun M, et al. Virome of post-weaned diarrhoeic pigs and healthy cohorts in England. Virol J. 2026. https://pubmed.ncbi.nlm.nih.gov/41935274/

[12] Gerber PF, Zhang J, Noel A, et al. Concomitant Infection With Porcine circovirus 2 and Porcine Epidemic Diarrhea Virus Does Not Increase Enteritis Severity in Experimentally Infected Weaned Piglets. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42046830/

[13] Li S, Bai L, Zhu X, et al. A novel PEDV-specific linear B-cell epitope evades cross-reactivity with TGEV and PDCoV. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42160787/

[14] Pan S, Wei L, Xiang Y, et al. Modification of N-glycosylation site in the spike protein enhances the neutralizing antibody response against PEDV. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41793877/

[15] Zhu F, Zong X, Xie X, et al. A direct and rapid RT-LAMP method for Point-of-Care test of porcine deltacoronavirus. J Virol Methods. 2026. https://pubmed.ncbi.nlm.nih.gov/42155855/

[16] Zeng H, Shi Y, Zhong Q, et al. RIG-I-dependent sensing of PEDV shapes epithelial antiviral immunity in the intestinal mucosa. J Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/42300736/

[17] Li S, Luo H, Zhang K, et al. The cholesterol transporter Niemann-Pick C1 facilitates the entry of porcine epidemic diarrhea coronavirus. J Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/42262129/

[18] Li X, Chen G, Yan Z, et al. Porcine epidemic diarrhea virus suppresses DHX9-mediated antiviral transcription through its nucleocapsid protein. Commun Biol. 2026. https://pubmed.ncbi.nlm.nih.gov/42249076/

[19] Hou C, Liu L, Chen X, et al. Bifunctional nanobodies enable rapid and ultrasensitive dual-antibody immunoassay of Porcine deltacoronavirus antigen. Biosens Bioelectron. 2026. https://pubmed.ncbi.nlm.nih.gov/42070446/

[20] Zeng L, Pan D, Huang Y, et al. Double proline-substituted porcine epidemic diarrhea virus full-length spike mRNA vaccine confers enhanced immunogenicity and protective efficacy compared to conventional inactivated vaccine. Vaccine. 2026. https://pubmed.ncbi.nlm.nih.gov/42142524/

[21] Zhang X, Wang H, Li K, et al. Dehydroevodiamine enhances PEDV vaccine efficacy through immune-gut microbiota modulation. Vaccine. 2026. https://pubmed.ncbi.nlm.nih.gov/41812636/

[22] Huang H, Wang X, Qin Y, et al. Swine acute diarrhea syndrome coronavirus nsp5 induces apoptosis by targeting GATA zinc finger domain-containing protein 2A (GATAD2A/p66α). mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42294686/

[23] Vasinioti VI, Giudice AL, Cordisco M, et al. Detection of bovine coronavirus in myocardial tissue of a naturally infected calf. One Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42294011/

[24] Peng J, Zhang WG, Wang H, et al. Cross-Talk Between Pyroptosis and Ferroptosis Promotes Intestinal Inflammation and Barrier Failure During PEDV Infection. Biomolecules. 2026. https://pubmed.ncbi.nlm.nih.gov/42193980/

[25] Kitashin I, Nakagawa K. Low prevalence and frequent co-detection of feline astrovirus with feline enteric coronavirus and feline bocaparvovirus in asymptomatic cats in Japan. Arch Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/42168424/

[26] Zheng YW, Chen CY, Chang CY, et al. Hydroxychloroquine inhibits porcine epidemic diarrhea virus infection by targeting post-attachment stages and virus-induced inflammation in vitro. Microb Pathog. 2026. https://pubmed.ncbi.nlm.nih.gov/42155905/

[27] Yan P, Kyaw ZO, Wang X, et al. Febrifugine dihydrochloride restricts porcine epidemic diarrhea virus replication by modulating the IGF1R-driven PI3K/AKT-apoptosis axis. J Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/41983768/

[28] Zhao Z, Yu R, Dai J, et al. Development of an S protein-based indirect ELISA for detecting IgA antibodies against porcine deltacoronavirus. Virology. 2026. https://pubmed.ncbi.nlm.nih.gov/41905251/

[29] Zhang B, Zhang G, Zhou J, et al. CdSe/ZnS quantum dot-labeled antibody fluorescent immunoassay strip for swine acute diarrhea syndrome coronavirus S1 protein detection. Anal Methods. 2026. https://pubmed.ncbi.nlm.nih.gov/41834521/

[30] Zhang J, Deng S, Zhang M, et al. Porcine epidemic diarrhea virus infection activates SREBP2 and induces RORγ expression to enhance cholesterol biosynthesis and virus replication. Antiviral Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41796918/

[31] Lu C, Xue X, Chen Z, et al. A20 restricted PDCoV release through negative regulation of PANoptosis. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/41773863/

[32] Xu Y, Zhang Y, Zhu H, et al. ANKFY1 suppresses PDCoV replication by degrading viral nsp8 protein via p62-dependent selective autophagy. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41763084/

[33] Zhang L, Liang Z, Yang G, et al. Elucidating the Molecular Mechanism of 3D1 Antibody Binding to a Swine Enteric Coronavirus Antigen. Viruses. 2026. https://pubmed.ncbi.nlm.nih.gov/41754551/

[34] Xiao J, Guo D, Xing X, et al. Phloretin targeting the 3CLpro Cys144 exhibits broad-spectrum antiviral activity against swine enteric coronavirus. Virol Sin. 2026. https://pubmed.ncbi.nlm.nih.gov/41720346/

[35] Luo Y, Feng Y, Ding S, et al. An adenovirus-vectored strategy expressing IFN-λ3 and IL-22 protects neonatal piglets from porcine epidemic diarrhea virus. Virology. 2026. https://pubmed.ncbi.nlm.nih.gov/41707571/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.